Affiliations: [a]
Department of Physical Therapy and Rehabilitation Science, University of Maryland School of Medicine, Baltimore, MD, USA
| [b]
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA
| [c]
Department of Exercise Science, Lebanon Valley College, Annville, PA, USA
Correspondence:
[*]
Corresponding author: Victoria Marchese, PT, PhD, Department of Physical Therapy and Rehabilitation Science, University of Maryland School of Medicine, 100 Penn Street, Baltimore, MD 21201, USA. Tel.: +1 717 7129622; E-mail: VMarchese@som.umaryland.edu.
Abstract: PURPOSE:This study explored neuromuscular mechanisms and clinical measures that contribute to countermovement jump performance in survivors of childhood acute lymphoblastic leukemia (ALL CCS) compared to age- and sex-matched peers. METHODS:This exploratory cross-sectional observational study examined 12 participants, six ALL CCS and six age- and sex-matched peers (7–16 years). During a countermovement jump, rates of muscle activation of lower leg muscles were measured with electromyography, and joint torques and peak jump height with force plates and a motion capture system. Clinical measures included muscle extensibility, balance, and mobility measured by active ankle dorsiflexion, Bruininks-Oseretsky Motor Proficiency (BOT-2), and Timed Up and Go (TUG) tests. RESULTS:Compared to peers, ALL CCS demonstrated reduced gastrocnemius muscle extensibility and tibialis anterior rate of muscle activation, decreased jump height, and poorer performance on the BOT-2 and TUG. Jump height was significantly correlated with clinical measures of the BOT-2 and TUG. CONCLUSION:These ALL CCS demonstrated neuromuscular impairments that may impact jump performance, an essential childhood physical activity. Further research is needed to explore intervention strategies to improve the neuromuscular mechanisms that contribute to high-level gross motor skills in ALL CCS.
Keywords: Cancer, motor skills, biomechanics, jumping
